Pages tagged “Controlled Substances Act”
-
Delta-8 THC and Delta-9 THC: What’s the Difference?
Delta-8 THC and delta-9 THC are both types of tetrahydrocannabinol (THC), the main compounds found in the cannabis plant. They have similar chemical structures but are regulated differently and have different safety profiles. This discussion focuses on these two aspects to better understand their potential effects and risks on our patients.
Written by Kelsey Engvik
November 26, 2024 -
Opportunities for Pharmacists in the Cannabis Industry: How to be Prepared
While cannabis as medicine is not new, the healthcare provider’s venture into the cannabis industry may be a new journey for many. In state medical marijuana programs doctors are the people who “recommend” cannabis (presently there is no actual prescription for cannabis).
Written by Megan Peterson
August 20, 2024 -
ACS – MCRAA Joint Comments on FDA Proposed Research Guidelines
The Medical Cannabis Research Advocacy Alliance (MCRAA) appreciates the opportunity to provide comments in response to the US Food and Drug Administration (FDA)’s Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Draft Guidance for Industry; Availability 85 FR 44305 (July 22, 2020).
Written by Jordan Tishler
February 25, 2024 -
ACS Letter To ONDCP Director Rahul Gupta
Dear Dr. Gupta:
Congratulations on the confirmation as Director of the Office of National Drug Control Policy. We welcome your leadership as our respective agendas are to improve and serve the health of the American people.
Written by Jordan Tishler
February 25, 2024 -
Association of Cannabinoid Specialists and the Medical Society of New Jersey Letter to Attorney General Merrick Garland
Dear Attorney General Garland:
Subsequent to the letter sent to you, and to Secretary Becerra, by Senators Warren and Booker dated October 6, 2021 requesting that you exercise your authority under the Controlled Substances Act of 1970 (CSA), we write to support their request and to support your pragmatic efforts to do so.
Written by Jordan Tishler
February 25, 2024 -
A Federal Framework of Regulation for Medical Cannabis Use
While a patchwork of state cannabis laws exists, the lack of a unified, federal framework regulating medical cannabis places patients at risk, and undermines the relationships that doctors must maintain to ensure an effective and safe treatment paradigm. Such a framework is both overdue and sorely needed for safe, optimized care of patients across the country.
Written by Jordan Tishler
February 20, 2024 -
Why Call It Cannabis?
Cannabis by any other name would work just the same. So why should we stick with calling it cannabis?
Written by Kelsey Engvik
October 09, 2023